Hu Wen Duan

Dr. Hu Wen Duan


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2016 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
BZBin Zhao
Bin Zhao
YLYixuan Li
Yixuan Li
PXPan Xu
Pan Xu
YDYang Dai
Yang Dai
CLCheng Luo
Cheng Luo
HDHu Wen Duan
Hu Wen Duan

12 July 2017 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
RMRuifeng Mao
Ruifeng Mao
JSJingwei Shao
Jingwei Shao
KZKongkai Zhu
Kongkai Zhu
YZYuanyuan Zhang
Yuanyuan Zhang
HDHong Ding
Hong Ding
CLCheng Luo
Cheng Luo

13 December 2022 in Cell Discovery
Verified
Journal Article
Open access
PDF file
ZXZuoquan Xie
Zuoquan Xie
ZWZhen Wang
Zhen Wang
FFFengying Fan
Fengying Fan
JZJinpei Zhou
Jinpei Zhou
ZHZhaoxue Hu
Zhaoxue Hu
MGMeiyu Geng
Meiyu Geng
Stimulator of interferon gene (STING) is increasingly exploited for the potential in cancer immunotherapy, yet its mechanism of activation remains not fully understood. Herein, we designed a novel STING agonist, designated as HB3089 that exhibits robust and durable anti-tumor activity in tumor models across various cancer types. Cryo-EM analysis reveals that HB3089-bound human STING has structural changes similar to that of the STING mutant V147L, a constitutively activated mutant identified in patients with STING-associated vasculopathy with onset in infancy (SAVI). Both structures highlight the conformational changes of the transmembrane domain (TMD), but without the 180°-rotation of the ligand binding domain (LBD) previously shown to be required for STING activation. Further structure-based functional analysis confirmed a new STING activation mode shared by the agonist and the SAVI-related mutation, in which the connector linking the LBD and the TMD senses the activation signal and controls the conformational changes of the LBD and the TMD for STING activation. Together, our findings lead to a new working model for STING activation and open a new avenue for the rationale design of STING-targeted therapies either for cancer or autoimmune disorders.

4 October 2018 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
ZZZhengsheng Zhan
Zhengsheng Zhan
XPXia Peng
Xia Peng
YSYiming Sun
Yiming Sun
JAJing Ai
Jing Ai
HDHu Wen Duan
Hu Wen Duan

6 July 2016 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
WYWei Yan
Wei Yan
XWXinyi Wang
Xinyi Wang
YDYang Dai
Yang Dai
BZBin Zhao
Bin Zhao
XYXinying Yang
Xinying Yang
HDHu Wen Duan
Hu Wen Duan

2 June 2021 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DDDaohai Du
Daohai Du
DXDandan Xu
Dandan Xu
LZLicheng Zhu
Licheng Zhu
GSGiulia Stazi
Giulia Stazi
Clemens ZwergelClemens Zwergel
Clemens Zwergel
CLCheng Luo
Cheng Luo